Senores Pharmaceuticals Ltd (SENORES) — Sustainability Report | 3 September 2026

Senores Pharmaceuticals Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26 to BSE and NSE on September 3, 2026, confirming standalone reporting basis. The filing details ESG disclosures across principles including governance, employee welfare, environmental stewardship, and stakeholder engagement. Key figures include 100% female employee coverage in awareness programs, 43.95% export contribution to turnover, and zero regulatory penalties. The company emphasized compliance with environmental laws, robust grievance mechanisms, and initiatives in water conservation and waste management. No independent assurance was obtained for ESG data.